Drug:
Reaction: INFLUENZA
20260101 - 20261231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 26459770 |
78 | 2 | |
Pneumonia, Influenza, Renal disorder, |
||||
POMALIDOMIDE, |
||||
| 602 | 26459975 |
47 | ||
Diarrhoea, Fatigue, Decreased immune responsiveness, Myalgia, Influenza, Product dose omission issue, |
||||
BIMEKIZUMAB, |
||||
| 603 | 26459993 |
CA |
41 | 2 |
Anaphylactic reaction, Anaphylactic shock, Amnesia, Abdominal distension, Arthropod bite, Asthenia, Bladder disorder, Blister, Blister rupture, Breast mass, COVID-19, Concussion, Contusion, Decreased appetite, Fall, Fatigue, Fibromyalgia, Food allergy, Foreign body in throat, Haemorrhage, Head injury, Hereditary angioedema, Hypoglycaemia, Incision site complication, Influenza, Localised infection, Loss of consciousness, Muscular weakness, Periarthritis, Road traffic accident, Skin laceration, Stress, Suspected COVID-19, Syncope, Synovial rupture, Thrombophlebitis, Tremor, Tympanic membrane perforation, Type 2 diabetes mellitus, Wrist fracture, Upper limb fracture, Vomiting, Wound infection, Heart rate increased, Dizziness, Insomnia, Nausea, Dyspnoea, Palpitations, Off label use, Drug ineffective, Product use issue, Product availability issue, |
||||
CELECOXIB, ICATIBANT ACETATE, ICATIBANT ACETATE, ICATIBANT ACETATE, ICATIBANT ACETATE, ICATIBANT ACETATE, ICATIBANT ACETATE, HYDROMORPHONE HYDROCHLORIDE, EPINEPHRINE, DALTEPARIN SODIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ORAL SEMAGLUTIDE, LEVOTHYROXINE SODIUM, TRANEXAMIC ACID, TRANEXAMIC ACID, TRANEXAMIC ACID, BUPROPION HYDROCHLORIDE, RIVAROXABAN, |
||||
| 604 | 26460185 |
US |
1 | |
Pneumonia viral, Influenza, Drug ineffective, |
||||
BENRALIZUMAB, BENRALIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 605 | 26460207 |
CA |
30 | 1 |
Neutropenia, Influenza, |
||||
CLOZAPINE, |
||||
| 606 | 26460481 |
US |
5 | 1 |
Influenza, |
||||
NUSINERSEN, |
||||
| 607 | 26462369 |
61 | 2 | |
Influenza, White blood cell count decreased, Dyspnoea exertional, |
||||
AMBRISENTAN, |
||||
| 608 | 26462378 |
61 | 2 | |
Dyspnoea, Influenza, White blood cell count decreased, |
||||
TADALAFIL, |
||||
| 609 | 26462445 |
61 | 2 | |
Dyspnoea exertional, Influenza, White blood cell count decreased, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 610 | 26462446 |
61 | 2 | |
Dyspnoea exertional, Influenza, White blood cell count decreased, |
||||
SELEXIPAG, |
||||
| 611 | 26462948 |
61 | 2 | |
Influenza, Pneumonia, Septic shock, Therapy interrupted, |
||||
SECUKINUMAB, |
||||
| 612 | 26452936 |
CA |
33 | |
Blood potassium increased, Influenza like illness, Malaise, Feeling abnormal, Blood creatinine increased, Influenza, Influenza, Off label use, Inappropriate schedule of product administration, Intentional product use issue, Therapy change, Intentional dose omission, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, MESALAMINE, |
||||
| 613 | 26453045 |
44 | ||
Seizure, Influenza, Loss of consciousness, Pyrexia, Headache, Stress, |
||||
BRIVARACETAM, BRIVARACETAM INJECTION, |
||||
| 614 | 26453206 |
US |
||
Influenza, |
||||
TIRZEPATIDE, |
||||
| 615 | 26453237 |
31 | ||
Injection site pain, Influenza, Eye pruritus, Urticaria, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 616 | 26453502 |
US |
||
Influenza, |
||||
BEVACIZUMAB-AWWB, |
||||
| 617 | 26453568 |
US |
||
Asthma, COVID-19, Influenza, |
||||
HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, ALBUTEROL SULFATE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 618 | 26453716 |
CA |
43 | |
Ageusia, Agitation, Allergy to animal, Anosmia, Body temperature decreased, Asthma, Facial pain, Choking, Chronic rhinosinusitis with nasal polyps, Discomfort, Dyspnoea, Dyspnoea at rest, Dyspnoea exertional, Frustration tolerance decreased, Insomnia, Irritability, Nasal congestion, Nasal obstruction, Oropharyngeal pain, Parosmia, Poor quality sleep, Poor venous access, SARS-CoV-2 test positive, Rhinorrhoea, Sensitivity to weather change, Sinus congestion, Sinus pain, Sneezing, Taste disorder, Temperature intolerance, Vomiting, Wheezing, Weight decreased, Nasopharyngitis, Diarrhoea infectious, Sinusitis, Influenza, Cough, Nausea, Fatigue, Headache, Inappropriate schedule of product administration, Therapeutic response decreased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, MOMETASONE FUROATE, MOMETASONE, MONTELUKAST, NAPROXEN, NAPROXEN SODIUM, TIOTROPIUM BROMIDE, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, |
||||
| 619 | 26453763 |
US |
28 | 2 |
Influenza, |
||||
GALCANEZUMAB-GNLM, |
||||
| 620 | 26453888 |
EU |
47 | 2 |
Rash, Pruritus, Illness, Alopecia, Scab, Dermatitis, Eczema, Dandruff, Influenza, Impaired work ability, General physical health deterioration, |
||||
ERGOCALCIFEROL, HYDROCORTISONE, |
||||
| 621 | 26454067 |
US |
2 | |
Influenza, |
||||
NUSINERSEN, |
||||
| 622 | 26454130 |
US |
72 | 2 |
Influenza, Full blood count decreased, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 623 | 26454260 |
KW |
2 | |
Drug ineffective, Inappropriate schedule of product administration, Influenza, Immune system disorder, |
||||
BORTEZOMIB, DARATUMUMAB, |
||||
| 624 | 26454267 |
US |
60 | 2 |
Influenza, Sluggishness, Dyspnoea, Decreased appetite, Oxygen saturation decreased, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GLIMEPIRIDE, SPIRONOLACTONE, ROSUVASTATIN, ALBUTEROL SULFATE, ALBUTEROL, TIRZEPATIDE, LOSARTAN, AMLODIPINE, |
||||
| 625 | 26455284 |
US |
57 | 2 |
Pulmonary thrombosis, Mobility decreased, Influenza, Thrombosis, Dyspnoea, Gait disturbance, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 626 | 26455579 |
US |
2 | |
Influenza, |
||||
| 627 | 26455583 |
US |
63 | 1 |
Influenza, Dysphonia, Sensitivity to weather change, Nasopharyngitis, |
||||
| 628 | 26455655 |
MX |
2 | |
Pneumonia, Respiratory syncytial virus test positive, Influenza, |
||||
PALIVIZUMAB, PALIVIZUMAB, PALIVIZUMAB, |
||||
| 629 | 26455706 |
2 | ||
Influenza, |
||||
TOBRAMYCIN, TOBRAMYCIN SOLUTION, TOBRAMYCIN SULFATE, |
||||
| 630 | 26455737 |
US |
92 | |
Influenza, Diarrhoea, Faeces discoloured, Product availability issue, Off label use, |
||||
RUXOLITINIB, RUXOLITINIB, |
||||
| 631 | 26455997 |
US |
80 | 2 |
Influenza, |
||||
POMALIDOMIDE, |
||||
| 632 | 26456074 |
US |
17 | |
Influenza, |
||||
RUXOLITINIB, |
||||
| 633 | 26456160 |
46 | ||
Injection site rash, Headache, Influenza, |
||||
OLEZARSEN SODIUM, |
||||
| 634 | 26456185 |
51 | ||
Influenza, |
||||
BIMEKIZUMAB, |
||||
| 635 | 26456477 |
US |
||
Pneumonia, Condition aggravated, Influenza, |
||||
C1 ESTERASE INHIBITOR RECOMBINANT, |
||||
| 636 | 26456640 |
US |
||
Influenza, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 637 | 26456756 |
GB |
76 | 2 |
Ventricular tachycardia, Malaise, Influenza, Haemoglobin decreased, Dysphagia, Fatigue, Dyspnoea, |
||||
RAVULIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 638 | 26456836 |
US |
||
Influenza, Hepatic enzyme increased, |
||||
PALOPEGTERIPARATIDE, CHLORTHALIDONE, ROSUVASTATIN, TIRZEPATIDE, |
||||
| 639 | 26448357 |
US |
74 | 2 |
Pneumonia, Influenza, Bronchitis, |
||||
DUPILUMAB, |
||||
| 640 | 26448714 |
JP |
9 | 1 |
Fall, Pain, Hand-foot-and-mouth disease, Streptococcal infection, Fall, Ligament sprain, Influenza, Weight increased, Fall, Birth mark, Obesity, Injection site pain, Nasopharyngitis, |
||||
| 641 | 26448906 |
CA |
59 | 2 |
Lower respiratory tract infection, Influenza, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
| 642 | 26448908 |
US |
2 | |
Malnutrition, Influenza, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, MIDODRINE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, PREGABALIN, LORAZEPAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, CITALOPRAM, CITALOPRAM HYDROBROMIDE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, ERGOCALCIFEROL, ALBUTEROL SULFATE, TIZANIDINE HYDROCHLORIDE, |
||||
| 643 | 26448917 |
US |
2 | |
Syncope, Dyspnoea, Influenza, Gastroenteritis viral, Flatulence, Product use complaint, Product dose omission issue, |
||||
TROFINETIDE, |
||||
| 644 | 26449545 |
US |
57 | 2 |
Crohn^s disease, Influenza, Bronchitis, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 645 | 26449585 |
US |
61 | 1 |
Influenza, |
||||
POMALIDOMIDE, |
||||
| 646 | 26449739 |
66 | ||
Psoriatic arthropathy, Influenza, Psoriasis, Inappropriate schedule of product administration, Therapy interrupted, Insurance issue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 647 | 26449863 |
CA |
65 | 2 |
Adjustment disorder, Affect lability, Anxiety, Aphasia, Arterial occlusive disease, Arthritis, Asthenia, Blood pressure increased, Carotid artery thrombosis, Cerebrovascular accident, Chest discomfort, Confusional state, Coordination abnormal, Cough, Cystitis, Dysarthria, Dysphagia, Eating disorder, Fall, Fatigue, Gangrene, Headache, Hemiparesis, Hemiplegia, Influenza, Influenza like illness, Malaise, Motor dysfunction, Muscle spasticity, Muscular weakness, Nasopharyngitis, Nausea, Neurologic neglect syndrome, Pain, Palpitations, Personality disorder, Pneumonia, Psoriasis, Pyrexia, Respiratory tract congestion, Rheumatoid arthritis, Rhinorrhoea, Sensory loss, Sinus congestion, Sinus disorder, Sinusitis, Skin exfoliation, Skin haemorrhage, Sneezing, Vomiting, |
||||
RITUXIMAB, RITUXIMAB, |
||||
| 648 | 26450072 |
US |
69 | 1 |
Influenza, Respiratory syncytial virus infection, |
||||
LENALIDOMIDE, |
||||
| 649 | 26450103 |
JP |
28 | 2 |
Headache, Influenza, Dizziness, Malaise, Muscular weakness, |
||||
NUSINERSEN, |
||||
| 650 | 26450131 |
JP |
25 | 2 |
Headache, Influenza, Malaise, Muscular weakness, Dizziness, |
||||
NUSINERSEN, |
||||
| 651 | 26450214 |
CA |
55 | 2 |
Abdominal discomfort, Alopecia, Anxiety, Apathy, Arthralgia, Asthenia, Back pain, Blister, Blood glucose increased, Blood pressure abnormal, Blood pressure increased, Blood sodium decreased, Body temperature abnormal, Body temperature decreased, Brain fog, Breast cancer in situ, COVID-19, Constipation, Cough, Decreased appetite, Decreased interest, Depression, Diabetes mellitus, Diarrhoea, Discouragement, Dizziness, Dizziness postural, Dysgeusia, Epistaxis, Erythema, Faeces discoloured, Fatigue, Fungal foot infection, Gastrointestinal disorder, Headache, Hyperhidrosis, Inappropriate schedule of product administration, Incorrect dose administered, Influenza, Influenza like illness, Livedo reticularis, Lower respiratory tract infection, Malaise, Memory impairment, Mental disorder, Muscle spasms, Muscular weakness, Musculoskeletal chest pain, Musculoskeletal discomfort, Myalgia, Nasopharyngitis, Nausea, Neuralgia, Pain, Pain in extremity, Pallor, Post-acute COVID-19 syndrome, Product dose omission issue, Productive cough, Pyrexia, Radiation associated pain, Rash pruritic, Sinusitis, Skin irritation, Sleep disorder, Suspected COVID-19, Vomiting, Weight decreased, Weight increased, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, SPIRONOLACTONE, SPIRONOLACTONE, SPIRONOLACTONE, SPIRONOLACTONE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ESTRADIOL, ESTRADIOL, ESTRADIOL, ESTRADIOL, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 652 | 26450676 |
CA |
49 | 1 |
Nephrolithiasis, Sinusitis, Influenza, Nasopharyngitis, |
||||
INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 653 | 26450743 |
CO |
32 | 2 |
Haematochezia, Somnolence, Abdominal discomfort, Anaemia, Abdominal pain, Dizziness, Vomiting, Stress, Drug ineffective, Amnesia, Weight increased, Rhinorrhoea, Malaise, Vision blurred, Nasal congestion, Headache, Cough, Influenza, Decreased appetite, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 654 | 26450879 |
1 | ||
Influenza, Therapy interrupted, |
||||
ALPELISIB, |
||||
| 655 | 26450963 |
US |
62 | 2 |
Gastroenteritis viral, Sinus disorder, Influenza, |
||||
TIRZEPATIDE, |
||||
| 656 | 26451133 |
US |
60 | |
Injection site pain, Influenza, |
||||
DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, |
||||
| 657 | 26451465 |
US |
20 | |
Influenza, Infective pulmonary exacerbation of cystic fibrosis, |
||||
ALBUTEROL SULFATE, AMIKACIN, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, OSELTAMIVIR, OSELTAMIVIR PHOSPHATE, DORNASE ALFA, RIFAMPIN, TOBRAMYCIN, TOBRAMYCIN SOLUTION, TOBRAMYCIN SULFATE, |
||||
| 658 | 26451484 |
US |
63 | 2 |
Respiratory symptom, Influenza, Skin lesion, Skin necrosis, Vasculitic ulcer, Cutaneous vasculitis, |
||||
PREDNISONE, PREDNISONE, DICLOFENAC, DICLOFENAC SODIUM, CLARITHROMYCIN, |
||||
| 659 | 26451510 |
US |
55 | 2 |
Influenza, |
||||
TIRZEPATIDE, |
||||
| 660 | 26451708 |
CO |
60 | 2 |
Knee operation, Influenza, Gait disturbance, |
||||
GOLIMUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 661 | 26451730 |
72 | 1 | |
Respiratory failure, Influenza, Pneumonia, |
||||
APALUTAMIDE, |
||||
| 662 | 26451944 |
CA |
2 | |
Influenza, Product dose omission issue, Rash pruritic, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, MAGNESIUM, MAGNESIUM, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ERGOCALCIFEROL, ERGOCALCIFEROL, VITAMIN C, VITAMIN C, |
||||
| 663 | 26452020 |
US |
75 | 2 |
Influenza, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 664 | 26452179 |
US |
91 | 1 |
Influenza, |
||||
LENALIDOMIDE, ACYCLOVIR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DICYCLOMINE HYDROCHLORIDE, DUTASTERIDE, FERROUS SULFATE, FLUTICASONE PROPIONATE, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MUPIROCIN, MUPIROCIN CALCIUM, NAPROXEN, NAPROXEN SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 665 | 26452220 |
55 | ||
Suffocation feeling, COVID-19, Arthralgia, Influenza, Wound, Product dispensing issue, Therapy interrupted, Off label use, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, LEFLUNOMIDE, HYDROXYCHLOROQUINE, |
||||
| 666 | 26452625 |
US |
||
Pneumonia, Influenza, Cough, |
||||
VORASIDENIB, |
||||
| 667 | 26452627 |
CA |
30 | 2 |
Clostridium difficile infection, Crohn^s disease, Influenza, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 668 | 26452657 |
47 | ||
Influenza, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 669 | 26452685 |
US |
||
Sepsis, Influenza, Urinary tract infection, |
||||
LENALIDOMIDE, |
||||
| 670 | 26452726 |
CA |
63 | 1 |
Haematoma, Eye irritation, Localised infection, Oedema peripheral, Influenza, Infection, Fall, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 671 | 26445991 |
US |
14 | 2 |
Influenza, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 672 | 26446068 |
US |
3 | 2 |
Pyrexia, Pruritus, Influenza, Respiratory syncytial virus infection, Ear infection, Cough, Sneezing, Vomiting, Therapeutic response shortened, Injection site pain, Rash, |
||||
DUPILUMAB, |
||||
| 673 | 26446076 |
CA |
84 | 1 |
Pulmonary oedema, Dyspnoea, Asthenia, Influenza, Decreased appetite, Oligodipsia, Cardiac disorder, Dysuria, White blood cell count increased, Mobility decreased, Urinary tract infection, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, RAMIPRIL, DAPAGLIFLOZIN, GABAPENTIN, GABAPENTIN, |
||||
| 674 | 26446319 |
CA |
82 | 2 |
Pneumonia, Influenza, |
||||
INFLIXIMAB, |
||||
| 675 | 26446357 |
US |
12 | 1 |
Pyrexia, Infection, Influenza, |
||||
DUPILUMAB, |
||||
| 676 | 26446492 |
US |
2 | |
Influenza, Pharyngitis streptococcal, Ear infection, Product use in unapproved indication, |
||||
DUPILUMAB, NAPROXEN, NAPROXEN SODIUM, |
||||
| 677 | 26446679 |
US |
63 | 2 |
Rash papular, Influenza, Nasopharyngitis, Cough, Furuncle, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 678 | 26446744 |
US |
49 | 2 |
Influenza, Nasal congestion, Body temperature increased, Arthralgia, Arthropathy, Osteoarthritis, Swelling, Bronchitis, Pneumonitis chemical, |
||||
UPADACITINIB, |
||||
| 679 | 26446815 |
US |
69 | 1 |
Influenza, |
||||
DUPILUMAB, |
||||
| 680 | 26446827 |
US |
67 | |
Influenza, Cardiomegaly, Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 681 | 26446830 |
US |
54 | 1 |
Influenza, Epistaxis, Upper respiratory tract infection, Anaemia, Pneumonia viral, Inappropriate schedule of product administration, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, |
||||
| 682 | 26446916 |
US |
3 | 1 |
Influenza, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 683 | 26447093 |
US |
16 | 2 |
Illness, Influenza, Ear infection, Dysphagia, Product dose omission issue, Sinusitis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 684 | 26447388 |
US |
1 | |
Influenza, Depressed mood, |
||||
DUPILUMAB, AMLODIPINE BESYLATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 685 | 26447769 |
US |
1 | 2 |
Influenza, |
||||
DUPILUMAB, |
||||
| 686 | 26447825 |
US |
2 | 1 |
Influenza, |
||||
DUPILUMAB, |
||||
| 687 | 26447950 |
US |
62 | 2 |
Influenza, Fatigue, |
||||
BELUMOSUDIL, AXATILIMAB-CSFR, |
||||
| 688 | 26447995 |
US |
53 | 1 |
Influenza, Dyspnoea, Quality of life decreased, Asthma, |
||||
DUPILUMAB, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BACLOFEN, BENZONATATE, BUDESONIDE, LORATADINE, LORATADINE TABLET, FAMOTIDINE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, FOLIC ACID, |
||||
| 689 | 26448197 |
US |
||
Pyrexia, Nasal congestion, Influenza like illness, Influenza, Intentional product use issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 690 | 26441318 |
GB |
||
Hypophagia, Diffuse large B-cell lymphoma stage IV, Back pain, Respiratory syncytial virus infection, Influenza, Pneumonia, Cytokine release syndrome, Abscess, |
||||
RITUXIMAB, POLATUZUMAB VEDOTIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, BISOPROLOL FUMARATE, RAMIPRIL, |
||||
| 691 | 26441671 |
EU |
55 | |
Enterocolitis, Diverticulum intestinal, Haemodynamic instability, Liver injury, Cytomegalovirus colitis, Clostridium difficile colitis, Enterococcal infection, Acinetobacter infection, Clostridium difficile infection, Cytomegalovirus infection, Influenza, Hypogammaglobulinaemia, Febrile neutropenia, Hepatitis, Hypovolaemia, Electrolyte imbalance, Intentional product use issue, Off label use, |
||||
RITUXIMAB, RITUXIMAB, BENDAMUSTINE HCL, BENDAMUSTINE HCL, BENDAMUSTINE HCL, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, DOXORUBICIN, VINCRISTINE SULFATE, VINCRISTINE SULFATE, PREDNISONE, PREDNISONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYTARABINE, CYTARABINE, CISPLATIN, CISPLATIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, GANCICLOVIR SODIUM, GANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, FIDAXOMICIN, CEFEPIME HYDROCHLORIDE, CEFEPIME, METRONIDAZOLE, METRONIDAZOLE TOPICAL, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, MEROPENEM, LINEZOLID, BENDAMUSTINE HCL, GANCICLOVIR SODIUM, GANCICLOVIR, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE, |
||||
| 692 | 26441754 |
US |
||
Myocardial infarction, Influenza, Pneumonia, Liquid product physical issue, |
||||
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE, |
||||
| 693 | 26441816 |
US |
||
Influenza, |
||||
BUROSUMAB, |
||||
| 694 | 26441882 |
EU |
2 | |
Autoimmune thyroiditis, Decompensated hypothyroidism, Liver disorder, Anxiety, Influenza, COVID-19, General physical health deterioration, Tremor, Palpitations, |
||||
| 695 | 26441916 |
US |
34 | 2 |
Nasopharyngitis, Influenza, Nausea, Hot flush, Vomiting, Weight decreased, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, KETAMINE HYDROCHLORIDE, HYDROCORTISONE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, CLONIDINE, KETOPROFEN, OXYGEN, 0XYGEN, SPIRONOLACTONE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, DAPAGLIFLOZIN, ENOXAPARIN SODIUM, GABAPENTIN, ONDANSETRON HYDROCHLORIDE, |
||||
| 696 | 26442172 |
US |
2 | |
Influenza, |
||||
DUPILUMAB, |
||||
| 697 | 26442599 |
EU |
76 | 1 |
Influenza, Tracheostomy, Hypertension, |
||||
FOSCARBIDOPA/FOSLEVODOPA, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, QUETIAPINE, LACTULOSE, TORSEMIDE, ESOMEPRAZOLE MAGNESIUM, |
||||
| 698 | 26442628 |
LK |
67 | 2 |
Influenza, Pyrexia, Chills, Cough, Neuropathy peripheral, Confusional state, |
||||
PEMBROLIZUMAB, TELMISARTAN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MORPHINE, |
||||
| 699 | 26442678 |
US |
1 | |
Influenza, Myasthenia gravis crisis, Product prescribing error, |
||||
RAVULIZUMAB, |
||||
| 700 | 26443048 |
CA |
78 | 2 |
Gastroenteritis, Abnormal loss of weight, Malaise, Decreased appetite, Asthenia, Influenza, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28